Replenish Nutrients Holding (ERTH) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
11 Jun, 2026Executive summary
Revenue, gross profit, gross profit percentage, funds used in operations, and adjusted EBITDA improved in Q2 2025 compared to the same quarter last year, driven by higher sales volumes, stronger pricing spreads, and lower SG&A expenses.
The Beiseker facility is producing high-quality granulated fertilizer, expected to be sold at 30%+ gross margin in the fall season.
Business development initiatives include discussions for a pelletized fertilizer version and potential licensing deals, anticipated to provide incremental margins and cash flows within the next year.
Financial highlights
Revenues increased by $0.6 million for the quarter but decreased by $0.3 million for the six months year-over-year; quarterly increase attributed to higher sales volumes and improved pricing spreads.
Gross profit decreased by $0.1 million for the quarter, but gross profit percentage rose by 6 percentage points, reflecting improved pricing spreads and lower input costs.
Net loss was flat for the quarter and decreased by $0.4 million for the six months compared to the prior year, mainly due to improved pricing and lower SG&A expenses.
Cash flows from operating activities decreased by $1.1 million for the quarter and $0.8 million for the six months, primarily due to increased working capital use.
Outlook and guidance
Positive trends in revenue and profitability are expected to continue as the Beiseker facility ramps up to full capacity and enters the busiest sales period in late Q3 and Q4.
Anticipated formalization of licensing and product development agreements is expected to enhance margins and cash flows within the next year.
Latest events from Replenish Nutrients Holding
- Scaling regenerative fertilizer with major partnerships and near-term cash flow targets.ERTH
Planet MicroCap Las Vegas 202617 Jun 2026 - Regenerative fertilizer platform scales through licensing and owned facilities, targeting rapid growth.ERTH
Investor presentation17 Jun 2026 - Regenerative fertilizer platform scales through licensing and owned facilities, capturing premium market growth.ERTH
Investor presentation17 Jun 2026 - Lower Q2 results offset by strong demand and margin growth expected from granulated fertilizer.ERTH
Q2 202411 Jun 2026 - Lower 2024 revenues offset by improved margins and cash flow; Beiseker ramp-up set for mid-2025.ERTH
Q4 202411 Jun 2026 - Gross profit margin improved to 19% and operating cash flow turned positive as production ramps up.ERTH
Q1 202511 Jun 2026 - Licensing deals and facility upgrades set the stage for stronger growth and margins in 2026.ERTH
Q3 202511 Jun 2026 - Expanded high-margin fertilizer production and licensing, but net loss increased on higher costs.ERTH
Q4 202511 Jun 2026 - Strong granulated fertilizer margins and record production offset by higher net loss in Q1 2026.ERTH
Q1 202611 Jun 2026